F2RL3 and ulcerative colitis: Similarly, our results did not show unmasking of the PAR4-based peptide by cathepsin G. This is in contrast with published data describing increased permeability in mice due to PAR4 activation by cathepsin G after intracolonic administration of fecal supernatant from patients with ulcerative colitis (UC) [51].